109 related articles for article (PubMed ID: 3365665)
1. High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma.
Onsrud M; Moxnes A; Sollien A; Grande T; Solesvik O
Cancer; 1988 Jun; 61(12):2429-32. PubMed ID: 3365665
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
Dana BW; McDermott M; Everts E; Abdulhay G
Am J Clin Oncol; 1987 Jun; 10(3):253-6. PubMed ID: 3296733
[TBL] [Abstract][Full Text] [Related]
3. High-dose metoclopramide as an antiemetic in patients receiving cis-platinum-based combination chemotherapy.
Gez E; Catane R; Pfau L; Biran S
Gynecol Oncol; 1985 May; 21(1):18-22. PubMed ID: 4039286
[TBL] [Abstract][Full Text] [Related]
4. Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting.
Allan SG; Cornbleet MA; Lockhart SP; Warrington PS; Leonard RC; Smyth JF
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1481-4. PubMed ID: 6389147
[TBL] [Abstract][Full Text] [Related]
5. High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis.
Rosenblatt E; Lev LM; Robinson E
Oncology; 1988; 45(4):297-9. PubMed ID: 3387033
[TBL] [Abstract][Full Text] [Related]
6. Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
Support Care Cancer; 1994 May; 2(3):167-70. PubMed ID: 8032702
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
8. Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.
Bécouarn Y; Nguyen BB; David M; Lakdja F; Brunet R; Chauvergne J
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1421-4. PubMed ID: 3595666
[TBL] [Abstract][Full Text] [Related]
9. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
[TBL] [Abstract][Full Text] [Related]
10. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
[TBL] [Abstract][Full Text] [Related]
11. Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis.
Saito H; Shimokata K; Yamori S; Kajita M; Niimi T
Am J Clin Oncol; 1994 Oct; 17(5):422-6. PubMed ID: 8092115
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
13. [Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis].
Dozono H; Ohmi K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):454-7. PubMed ID: 3954370
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
De Mulder PH; Seynaeve C; Vermorken JB; van Liessum PA; Mols-Jevdevic S; Allman EL; Beranek P; Verweij J
Ann Intern Med; 1990 Dec; 113(11):834-40. PubMed ID: 2146911
[TBL] [Abstract][Full Text] [Related]
15. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
Grunberg SM; Gala KV; Lampenfeld M; Jamin D; Johnson K; Cariffe P; Strych D; Krailo M
J Clin Oncol; 1984 Jul; 2(7):782-7. PubMed ID: 6539812
[TBL] [Abstract][Full Text] [Related]
17. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
Aapro MS; Plezia PM; Alberts DS; Graham V; Jones SE; Surwit EA; Moon TE
J Clin Oncol; 1984 May; 2(5):466-71. PubMed ID: 6539363
[TBL] [Abstract][Full Text] [Related]
18. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
[TBL] [Abstract][Full Text] [Related]
20. Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
Sorbe B; Hallén C; Skåre NG; Underskog I
Radiother Oncol; 1989 Jun; 15(2):161-7. PubMed ID: 2762589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]